DC

David C. Lubner

Board Director

Structure Therapeutics

Structure Therapeutics Pipeline

DrugIndicationPhase
GSBR-1290ObesityPhase 2
ANPA-0073Pulmonary Arterial Hypertension (PAH)Preclinical
LTSE-2578ObesityPreclinical